{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:26:57Z","timestamp":1790713617854,"version":"4.1.0"},"reference-count":164,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":2503,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Gabrielle's Angel Research Foundation"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA66996"],"award-info":[{"award-number":["CA66996"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA140575"],"award-info":[{"award-number":["CA140575"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA176745"],"award-info":[{"award-number":["CA176745"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","exphem.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.exphem.2015.05.012","type":"journal-article","created":{"date-parts":[[2015,6,25]],"date-time":"2015-06-25T14:54:58Z","timestamp":1435244098000},"page":"673-684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":115,"title":["Targeting DOT1L and HOX gene expression in MLL-rearranged leukemia and beyond"],"prefix":"10.1016","volume":"43","author":[{"given":"Chun-Wei","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2015.05.012_bib1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0165-4608(82)90012-7","article-title":"4;11 translocation in acute lymphoblastic leukemia: a specific syndrome","volume":"7","author":"Morse","year":"1982","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.exphem.2015.05.012_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF00289443","article-title":"Chromosomes in acute leukemia","volume":"53","author":"Prigogina","year":"1979","journal-title":"Hum Genet"},{"key":"10.1016\/j.exphem.2015.05.012_bib3","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF00291919","article-title":"A new chromosome anomaly in acute lymphoblastic leukemia (ALL)","volume":"46","author":"Van den Berghe","year":"1979","journal-title":"Hum Genet"},{"key":"10.1016\/j.exphem.2015.05.012_bib4","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1182\/blood.V67.3.689.689","article-title":"Clinical and laboratory characteristics of acute leukemia with the 4;11 translocation","volume":"67","author":"Mirro","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.012_bib5","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1182\/blood.V66.5.1115.1115","article-title":"Acute mixed lineage leukemia: clinicopathologic correlations and prognostic significance","volume":"66","author":"Mirro","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.012_bib6","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/S0046-8177(85)80125-8","article-title":"Unexpected heterogeneity in acute leukemia: mixed lineages and lineage switch","volume":"16","author":"Stass","year":"1985","journal-title":"Hum Pathol"},{"key":"10.1016\/j.exphem.2015.05.012_bib7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/ng1092-113","article-title":"A trithorax-like gene is interrupted by chromosome 11q23 translocations in acute leukaemias","volume":"2","author":"Djabali","year":"1992","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2015.05.012_bib8","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0092-8674(92)90603-A","article-title":"The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene","volume":"71","author":"Gu","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2015.05.012_bib9","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0092-8674(92)90602-9","article-title":"Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias","volume":"71","author":"Tkachuk","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2015.05.012_bib10","doi-asserted-by":"crossref","first-page":"10735","DOI":"10.1073\/pnas.88.23.10735","article-title":"Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias","volume":"88","author":"Ziemin-van der Poel","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2015.05.012_bib11","doi-asserted-by":"crossref","first-page":"6306","DOI":"10.1200\/JCO.2005.05.047","article-title":"Molecular genetics of acute lymphoblastic leukemia","volume":"23","author":"Armstrong","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2015.05.012_bib12","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/sj.leu.2402135","article-title":"An atlas of chromosomes in hematological malignancies. Example: 11q23 and MLL partners","volume":"15","author":"Huret","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.05.012_bib13","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nrc2253","article-title":"MLL translocations, histone modifications and leukaemia stem-cell development","volume":"7","author":"Krivtsov","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2015.05.012_bib14","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/leu.2009.33","article-title":"Oncogenes, fusion genes and tumor suppressor genes: new insights to the MLL recombinome of acute leukemias","volume":"23","author":"Meyer","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.05.012_bib15","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/sj.leu.2404150","article-title":"The MLL recombinome of acute leukemias","volume":"20","author":"Meyer","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.05.012_bib16","first-page":"3707","article-title":"Chromosomal abnormalities in 478 children with acute myeloid leukemia: clinical characteristics and treatment outcome in a cooperative Pediatric Oncology Group study\u2014POG 8821","volume":"94","author":"Raimondi","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.012_bib17","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc2915","article-title":"Licensed to elongate: a molecular mechanism for MLL-based leukaemogenesis","volume":"10","author":"Mohan","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2015.05.012_bib18","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/sj.leu.2402468","article-title":"Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia working party","volume":"16","author":"Chessells","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.05.012_bib19","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1182\/blood-2005-07-3011","article-title":"Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group","volume":"108","author":"Hilden","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.012_bib20","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0140-6736(07)61126-X","article-title":"A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial","volume":"370","author":"Pieters","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.exphem.2015.05.012_bib21","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1038\/sj.leu.2404903","article-title":"Outcome of risk-based therapy for infant acute lymphoblastic leukemia with or without an MLL gene rearrangement, with emphasis on late effects: a final report of two consecutive studies, MLL96 and MLL98, of the Japan Infant Leukemia Study Group","volume":"21","author":"Tomizawa","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.05.012_bib22","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1182\/blood-2009-02-204214","article-title":"Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99 protocol","volume":"114","author":"Van der Linden","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.012_bib23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1182\/blood.V96.1.24","article-title":"Biological and therapeutic aspects of infant leukemia","volume":"96","author":"Biondi","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.012_bib24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-4608(99)00250-2","article-title":"The \u201cAtlas of genetics and cytogenetics in oncology and haematology\u201d on the Internet and a\u00a0review on infant leukemias","volume":"120","author":"Huret","year":"2000","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.exphem.2015.05.012_bib25","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1182\/blood.V85.11.3250.bloodjournal85113250","article-title":"ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children","volume":"85","author":"Felix","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.012_bib26","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0167-4781(98)00139-0","article-title":"Secondary leukemias induced by topoisomerase-targeted drugs","volume":"1400","author":"Felix","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.exphem.2015.05.012_bib27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1365-2141.2000.01843.x","article-title":"Topoisomerase II inhibitor-related acute myeloid leukaemia","volume":"109","author":"Pui","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2015.05.012_bib28","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1038\/leu.2013.135","article-title":"The MLL recombinome of acute leukemias in 2013","volume":"27","author":"Meyer","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.05.012_bib29","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1182\/blood-2003-02-0434","article-title":"AML with 11q23\/MLL abnormalities as defined by the WHO classification: Incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases","volume":"102","author":"Schoch","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.012_bib30","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ng.3230","article-title":"The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias","volume":"47","author":"Andersson","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2015.05.012_bib31","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood.V81.9.2386.2386","article-title":"Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome","volume":"81","author":"Chen","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.012_bib32","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1182\/blood-2004-04-1616","article-title":"Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital","volume":"104","author":"Pui","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.012_bib33","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1182\/blood-2004-04-1390","article-title":"Infant acute lymphoblastic leukemia with MLL gene rearrangements: outcome following intensive chemotherapy and hematopoietic stem cell transplantation","volume":"104","author":"Kosaka","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.012_bib34","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1182\/blood-2010-03-273532","article-title":"Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of infants with mixed-lineage-leukemia (MLL)-rearranged acute lymphoblastic leukemia: results from the Interfant-99 Study","volume":"116","author":"Mann","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.012_bib35","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev-pathol-011811-132434","article-title":"The pathogenesis of mixed-lineage leukemia","volume":"7","author":"Muntean","year":"2012","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.exphem.2015.05.012_bib36","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1365-2141.2004.05038.x","article-title":"Classical and molecular cytogenetic abnormalities and outcome of childhood acute myeloid leukaemia: report from a referral centre in Israel","volume":"126","author":"Stark","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2015.05.012_bib37","doi-asserted-by":"crossref","first-page":"10753","DOI":"10.1074\/jbc.C200023200","article-title":"COMPASS, a histone H3 (Lysine 4) methyltransferase required for telomeric silencing of gene expression","volume":"277","author":"Krogan","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2015.05.012_bib38","doi-asserted-by":"crossref","first-page":"12902","DOI":"10.1073\/pnas.231473398","article-title":"COMPASS: A complex of proteins associated with a trithorax-related SET domain protein","volume":"98","author":"Miller","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2015.05.012_bib39","doi-asserted-by":"crossref","first-page":"7137","DOI":"10.1093\/emboj\/20.24.7137","article-title":"The Saccharomyces cerevisiae Set1 complex includes an Ash2 homologue and methylates histone 3 lysine 4","volume":"20","author":"Roguev","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.exphem.2015.05.012_bib40","doi-asserted-by":"crossref","first-page":"10610","DOI":"10.1073\/pnas.91.22.10610","article-title":"11q23 translocations split the \u201cAT-hook\u201d cruciform DNA-binding region and the transcriptional repression domain from the activation domain of the mixed-lineage leukemia (MLL) gene","volume":"91","author":"Zeleznik-Le","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2015.05.012_bib41","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/nar\/30.4.958","article-title":"The MT domain of the proto-oncoprotein MLL binds to CpG-containing DNA and discriminates against methylation","volume":"30","author":"Birke","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.exphem.2015.05.012_bib42","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1128\/MCB.21.10.3589-3597.2001","article-title":"Protein interactions of the MLL PHD fingers modulate MLL target gene regulation in human cells","volume":"21","author":"Fair","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2015.05.012_bib43","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1101\/gad.940201","article-title":"Histone H3 lysine 4 methylation is mediated by Set1 and required for cell growth and rDNA silencing in Saccharomyces cerevisiae","volume":"15","author":"Briggs","year":"2001","journal-title":"Genes Dev"},{"key":"10.1016\/j.exphem.2015.05.012_bib44","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S1097-2765(02)00741-4","article-title":"MLL targets SET domain methyltransferase activity to Hox gene promoters","volume":"10","author":"Milne","year":"2002","journal-title":"Mol Cell"},{"key":"10.1016\/j.exphem.2015.05.012_bib45","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1128\/MCB.23.1.186-194.2003","article-title":"Proteolytic cleavage of MLL generates a complex of N- and C-terminal fragments that confers protein stability and subnuclear localization","volume":"23","author":"Hsieh","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2015.05.012_bib46","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1182\/blood-2002-04-1015","article-title":"Leukemia proto-oncoprotein MLL is proteolytically processed into 2 fragments with opposite transcriptional properties","volume":"100","author":"Yokoyama","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.012_bib47","doi-asserted-by":"crossref","first-page":"14765","DOI":"10.1073\/pnas.0503630102","article-title":"MLL associates specifically with a subset of transcriptionally active target genes","volume":"102","author":"Milne","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2015.05.012_bib48","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S1097-2765(02)00740-2","article-title":"ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation","volume":"10","author":"Nakamura","year":"2002","journal-title":"Mol Cell"},{"key":"10.1016\/j.exphem.2015.05.012_bib49","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nsmb1116","article-title":"Molecular recognition of histone H3 by the WD40 protein WDR5","volume":"13","author":"Couture","year":"2006","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.exphem.2015.05.012_bib50","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nsmb1128","article-title":"Regulation of MLL1 H3K4 methyltransferase activity by its core components","volume":"13","author":"Dou","year":"2006","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.exphem.2015.05.012_bib51","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/nsmb1131","article-title":"Molecular regulation of H3K4 trimethylation by ASH2L, a shared subunit of MLL complexes","volume":"13","author":"Steward","year":"2006","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.exphem.2015.05.012_bib52","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1021\/cb600367v","article-title":"MLL core components give the green light to histone methylation","volume":"1","author":"Crawford","year":"2006","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.exphem.2015.05.012_bib53","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1101\/gad.254870.114","article-title":"A phosphorylation switch on RbBP5 regulates histone H3 Lys4 methylation","volume":"29","author":"Zhang","year":"2015","journal-title":"Genes Dev"},{"key":"10.1016\/j.exphem.2015.05.012_bib54","doi-asserted-by":"crossref","first-page":"6361","DOI":"10.1074\/jbc.M114.627646","article-title":"Biochemical reconstitution and phylogenetic comparison of human SET1 family core complexes involved in histone methylation","volume":"290","author":"Shinsky","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2015.05.012_bib55","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1016\/j.jmb.2014.03.011","article-title":"A non-active-site SET domain surface crucial for the interaction of MLL1 and the RbBP5\/Ash2L heterodimer within MLL family core complexes","volume":"426","author":"Shinsky","year":"2014","journal-title":"J Mol Biol"},{"key":"10.1016\/j.exphem.2015.05.012_bib56","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1074\/jbc.M113.501064","article-title":"Automethylation activities within the mixed lineage leukemia-1 (MLL1) core complex reveal evidence supporting a \u201ctwo-active site\u201d model for multiple histone H3 lysine 4 methylation","volume":"289","author":"Patel","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2015.05.012_bib57","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1146\/annurev-biochem-051710-134100","article-title":"The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis","volume":"81","author":"Shilatifard","year":"2012","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.exphem.2015.05.012_bib58","doi-asserted-by":"crossref","first-page":"6074","DOI":"10.1128\/MCB.00924-09","article-title":"Global analysis of H3K4 methylation defines MLL family member targets and points to a role for MLL1-mediated H3K4 methylation in the regulation of transcriptional initiation by RNA polymerase II","volume":"29","author":"Wang","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2015.05.012_bib59","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/ng765","article-title":"MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia","volume":"30","author":"Armstrong","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2015.05.012_bib60","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1172\/JCI25546","article-title":"Mll partial tandem duplication induces aberrant Hox expression in\u00a0vivo via specific epigenetic alterations","volume":"116","author":"Dorrance","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2015.05.012_bib61","doi-asserted-by":"crossref","first-page":"11367","DOI":"10.1158\/0008-5472.CAN-05-1041","article-title":"Leukemogenic MLL fusion proteins bind across a broad region of the Hox a9 locus, promoting transcription and multiple histone modifications","volume":"65","author":"Milne","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2015.05.012_bib62","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1182\/blood-2002-10-3221","article-title":"Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation","volume":"102","author":"Ferrando","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.012_bib63","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1535-6108(02)00032-6","article-title":"Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling","volume":"1","author":"Yeoh","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2015.05.012_bib64","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1182\/blood-2003-01-0338","article-title":"Classification of pediatric acute lymphoblastic leukemia by gene expression profiling","volume":"102","author":"Ross","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.012_bib65","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/sj.leu.2401410","article-title":"Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells","volume":"13","author":"Kawagoe","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.05.012_bib66","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/01.moh.0000160737.52349.aa","article-title":"Hox regulation of normal and leukemic hematopoietic stem cells","volume":"12","author":"Abramovich","year":"2005","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.exphem.2015.05.012_bib67","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/leu.2012.356","article-title":"The role of HOX genes in normal hematopoiesis and acute leukemia","volume":"27","author":"Alharbi","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.05.012_bib68","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/378505a0","article-title":"Altered Hox expression and segmental identity in Mll-mutant mice","volume":"378","author":"Yu","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2015.05.012_bib69","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1182\/blood.V90.5.1799","article-title":"Defects in yolk sac hematopoiesis in Mll-null embryos","volume":"90","author":"Hess","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.012_bib70","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1182\/blood.V92.1.108.413k11_108_117","article-title":"Growth disturbance in fetal liver hematopoiesis of Mll-mutant mice","volume":"92","author":"Yagi","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.012_bib71","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1534-5807(04)00061-9","article-title":"Definitive hematopoiesis requires the mixed-lineage leukemia gene","volume":"6","author":"Ernst","year":"2004","journal-title":"Dev Cell"},{"key":"10.1016\/j.exphem.2015.05.012_bib72","doi-asserted-by":"crossref","first-page":"8603","DOI":"10.1073\/pnas.0503072102","article-title":"Global and Hox-specific roles for the MLL1 methyltransferase","volume":"102","author":"Guenther","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2015.05.012_bib73","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S1097-2765(04)00081-4","article-title":"Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus","volume":"13","author":"Hughes","year":"2004","journal-title":"Mol Cell"},{"key":"10.1016\/j.exphem.2015.05.012_bib74","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.cell.2005.09.025","article-title":"The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis","volume":"123","author":"Yokoyama","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2015.05.012_bib75","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1128\/MCB.24.13.5639-5649.2004","article-title":"Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression","volume":"24","author":"Yokoyama","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2015.05.012_bib76","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ccell.2015.02.016","article-title":"Pharmacologic inhibition of the menin-MLL interaction blocks progression of MLL leukemia in\u00a0vivo","volume":"27","author":"Borkin","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2015.05.012_bib77","doi-asserted-by":"crossref","first-page":"6629","DOI":"10.1073\/pnas.0507425103","article-title":"Histone and DNA methylation defects at Hox genes in mice expressing a SET domain-truncated form of Mll","volume":"103","author":"Terranova","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2015.05.012_bib78","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.celrep.2014.04.015","article-title":"The histone methyltransferase activity of MLL1 is dispensable for hematopoiesis and leukemogenesis","volume":"7","author":"Mishra","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.exphem.2015.05.012_bib79","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrc2826","article-title":"The Hox genes and their roles in oncogenesis","volume":"10","author":"Shah","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2015.05.012_bib80","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ccr.2011.06.010","article-title":"MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L","volume":"20","author":"Bernt","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2015.05.012_bib81","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1093\/emboj\/17.13.3714","article-title":"Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b","volume":"17","author":"Kroon","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/j.exphem.2015.05.012_bib82","first-page":"301","article-title":"Homeobox genes in leukemogenesis","volume":"71","author":"Buske","year":"2000","journal-title":"Int J Hematol"},{"key":"10.1016\/j.exphem.2015.05.012_bib83","doi-asserted-by":"crossref","first-page":"6895","DOI":"10.1182\/blood-2010-12-324699","article-title":"MLL fusion proteins preferentially regulate a subset of wild-type MLL target genes in the leukemic genome","volume":"117","author":"Wang","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.012_bib84","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ccr.2009.12.034","article-title":"MLL-AF9-induced leukemogenesis requires coexpression of the wild-type Mll allele","volume":"17","author":"Thiel","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2015.05.012_bib85","doi-asserted-by":"crossref","first-page":"7884","DOI":"10.1073\/pnas.90.16.7884","article-title":"Acute mixed-lineage leukemia t(4;11)(q21;q23) generates an MLL-AF4 fusion product","volume":"90","author":"Domer","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2015.05.012_bib86","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0092-8674(00)81269-6","article-title":"An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes","volume":"85","author":"Corral","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2015.05.012_bib87","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/embo-reports\/kvd021","article-title":"Inter-chromosomal recombination of Mll and Af9 genes mediated by cre-loxP in mouse development","volume":"1","author":"Collins","year":"2000","journal-title":"EMBO Rep"},{"key":"10.1016\/j.exphem.2015.05.012_bib88","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1535-6108(03)00106-5","article-title":"Engineering de novo reciprocal chromosomal translocations associated with Mll to replicate primary events of human cancer","volume":"3","author":"Forster","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2015.05.012_bib89","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ccr.2008.10.001","article-title":"H3K79 methylation profiles define murine and human MLL-AF4 leukemias","volume":"14","author":"Krivtsov","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2015.05.012_bib90","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1182\/blood-2005-08-3498","article-title":"A murine Mll-AF4 knock-in model results in lymphoid and myeloid deregulation and hematologic malignancy","volume":"108","author":"Chen","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.012_bib91","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1038\/sj.onc.1209636","article-title":"A conditional model of MLL-AF4 B-cell tumourigenesis using invertor technology","volume":"25","author":"Metzler","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2015.05.012_bib92","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/ng.2007.21","article-title":"RNA polymerase is poised for activation across the genome","volume":"39","author":"Muse","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2015.05.012_bib93","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.cell.2008.04.027","article-title":"Poised RNA polymerase II gives pause for thought","volume":"133","author":"Margaritis","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2015.05.012_bib94","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1126\/science.271.5257.1873","article-title":"An RNA polymerase II elongation factor encoded by the human ELL gene","volume":"271","author":"Shilatifard","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.exphem.2015.05.012_bib95","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1146\/annurev.biochem.72.121801.161551","article-title":"The RNA polymerase II elongation complex","volume":"72","author":"Shilatifard","year":"2003","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.exphem.2015.05.012_bib96","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1182\/blood-2007-05-090514","article-title":"A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification","volume":"110","author":"Mueller","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.012_bib97","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/hmg\/ddl444","article-title":"The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling","volume":"16","author":"Bitoun","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.exphem.2015.05.012_bib98","doi-asserted-by":"crossref","first-page":"9894","DOI":"10.1073\/pnas.152193699","article-title":"dELL is an essential RNA polymerase II elongation factor with a general role in development","volume":"99","author":"Eissenberg","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2015.05.012_bib99","doi-asserted-by":"crossref","first-page":"6104","DOI":"10.1093\/emboj\/20.21.6104","article-title":"Drosophila ELL is associated with actively elongating RNA polymerase II on transcriptionally active sites in\u00a0vivo","volume":"20","author":"Gerber","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.exphem.2015.05.012_bib100","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.molcel.2006.06.014","article-title":"Controlling the elongation phase of transcription with P-TEFb","volume":"23","author":"Peterlin","year":"2006","journal-title":"Mol Cell"},{"key":"10.1016\/j.exphem.2015.05.012_bib101","doi-asserted-by":"crossref","first-page":"e1000249","DOI":"10.1371\/journal.pbio.1000249","article-title":"Misguided transcriptional elongation causes mixed lineage leukemia","volume":"7","author":"Mueller","year":"2009","journal-title":"PLoS Biol"},{"key":"10.1016\/j.exphem.2015.05.012_bib102","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.exphem.2010.09.003","article-title":"MLL-AF9 and MLL-ENL alter the dynamic association of transcriptional regulators with genes critical for leukemia","volume":"39","author":"Monroe","year":"2011","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2015.05.012_bib103","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ccr.2009.12.040","article-title":"A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcription","volume":"17","author":"Yokoyama","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2015.05.012_bib104","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.molcel.2010.01.026","article-title":"AFF4, a component of the ELL\/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia","volume":"37","author":"Lin","year":"2010","journal-title":"Mol Cell"},{"key":"10.1016\/j.exphem.2015.05.012_bib105","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/47412","article-title":"The language of covalent histone modifications","volume":"403","author":"Strahl","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2015.05.012_bib106","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nrm3890","article-title":"Histone core modifications regulating nucleosome structure and dynamics","volume":"15","author":"Tessarz","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.exphem.2015.05.012_bib107","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/35020506","article-title":"Regulation of chromatin structure by site-specific histone H3 methyltransferases","volume":"406","author":"Rea","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2015.05.012_bib108","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1101\/gad.1741408","article-title":"Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia","volume":"22","author":"Guenther","year":"2008","journal-title":"Genes Dev"},{"key":"10.1016\/j.exphem.2015.05.012_bib109","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.cell.2007.05.009","article-title":"High-resolution profiling of histone methylations in the human genome","volume":"129","author":"Barski","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2015.05.012_bib110","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1128\/MCB.02076-07","article-title":"DOT1L\/KMT4 recruitment and H3K79 methylation are ubiquitously coupled with gene transcription in mammalian cells","volume":"28","author":"Steger","year":"2008","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2015.05.012_bib111","doi-asserted-by":"crossref","first-page":"18346","DOI":"10.1074\/jbc.M300890200","article-title":"Dynamic regulation of histone H3 methylated at lysine 79 within a tissue-specific chromatin domain","volume":"278","author":"Im","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2015.05.012_bib112","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1101\/gad.1198204","article-title":"The histone modification pattern of active genes revealed through genome-wide chromatin analysis of a higher eukaryote","volume":"18","author":"Sch\u00fcbeler","year":"2004","journal-title":"Genes Dev"},{"key":"10.1016\/j.exphem.2015.05.012_bib113","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cell.2007.05.042","article-title":"A chromatin landmark and transcription initiation at most promoters in human cells","volume":"130","author":"Guenther","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2015.05.012_bib114","doi-asserted-by":"crossref","first-page":"30421","DOI":"10.1074\/jbc.C200366200","article-title":"Disruptor of telomeric silencing-1 is a chromatin-specific histone H3 methyltransferase","volume":"277","author":"Lacoste","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2015.05.012_bib115","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0092-8674(02)00759-6","article-title":"Dot1p modulates silencing in yeast by methylation of the nucleosome core","volume":"109","author":"Van Leeuwen","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2015.05.012_bib116","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/S0960-9822(02)00901-6","article-title":"Methylation of H3-lysine 79 is mediated by a new family of HMTases without a SET domain","volume":"12","author":"Feng","year":"2002","journal-title":"Curr Biol"},{"key":"10.1016\/j.exphem.2015.05.012_bib117","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/genetics\/150.2.613","article-title":"Identification of high-copy disruptors of telomeric silencing in Saccharomyces cerevisiae","volume":"150","author":"Singer","year":"1998","journal-title":"Genetics"},{"key":"10.1016\/j.exphem.2015.05.012_bib118","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1534\/genetics.104.033191","article-title":"Characterization of the grappa gene, the Drosophila histone H3 lysine 79 methyltransferase","volume":"169","author":"Shanower","year":"2005","journal-title":"Genetics"},{"key":"10.1016\/j.exphem.2015.05.012_bib119","doi-asserted-by":"crossref","first-page":"e1000190","DOI":"10.1371\/journal.pgen.1000190","article-title":"The histone H3K79 methyltransferase Dot1L is essential for mammalian development and heterochromatin structure","volume":"4","author":"Jones","year":"2008","journal-title":"PLoS Genet"},{"key":"10.1016\/j.exphem.2015.05.012_bib120","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1101\/gad.2057811","article-title":"The diverse functions of Dot1 and H3K79 methylation","volume":"25","author":"Nguyen","year":"2011","journal-title":"Genes Dev"},{"key":"10.1016\/j.exphem.2015.05.012_bib121","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1182\/blood-2010-03-276501","article-title":"Early mammalian erythropoiesis requires the Dot1L methyltransferase","volume":"116","author":"Feng","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.012_bib122","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1182\/blood-2010-12-327668","article-title":"Requirement for Dot1l in murine postnatal hematopoiesis and leukemogenesis by MLL translocation","volume":"117","author":"Jo","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.012_bib123","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/cr.2011.115","article-title":"Essential role of DOT1L in maintaining normal adult hematopoiesis","volume":"21","author":"Nguyen","year":"2011","journal-title":"Cell Res"},{"key":"10.1016\/j.exphem.2015.05.012_bib124","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1101\/gad.1898410","article-title":"Linking H3K79 trimethylation to Wnt signaling through a novel Dot1-containing complex (DotCom)","volume":"24","author":"Mohan","year":"2010","journal-title":"Genes Dev"},{"key":"10.1016\/j.exphem.2015.05.012_bib125","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cell.2005.02.020","article-title":"hDOT1L links histone methylation to leukemogenesis","volume":"121","author":"Okada","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2015.05.012_bib126","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10930-010-9242-8","article-title":"Characterization of the DOT1L network: implications of diverse roles for DOT1L","volume":"29","author":"Park","year":"2010","journal-title":"Protein J"},{"key":"10.1016\/j.exphem.2015.05.012_bib127","doi-asserted-by":"crossref","first-page":"30585","DOI":"10.1074\/jbc.M113.457135","article-title":"Targeting recruitment of disruptor of telomeric silencing 1-like (DOT1L): characterizing the interactions between DOT1L and mixed lineage leukemia (MLL) fusion proteins","volume":"288","author":"Shen","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2015.05.012_bib128","doi-asserted-by":"crossref","first-page":"18059","DOI":"10.1074\/jbc.M601903200","article-title":"Dot1a-AF9 complex mediates histone H3 Lys-79 hypermethylation and repression of ENaCalpha in an aldosterone-sensitive manner","volume":"281","author":"Zhang","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2015.05.012_bib129","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.ccell.2014.10.009","article-title":"AF10 regulates progressive H3K79 methylation and HOX gene expression in diverse AML subtypes","volume":"26","author":"Deshpande","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2015.05.012_bib130","doi-asserted-by":"crossref","first-page":"15751","DOI":"10.1073\/pnas.1111498108","article-title":"Function of leukemogenic mixed lineage leukemia 1 (MLL) fusion proteins through distinct partner protein complexes","volume":"108","author":"Biswas","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2015.05.012_bib131","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/leu.2012.327","article-title":"Abrogation of MLL-AF10 and CALM-AF10-mediated transformation through genetic inactivation or pharmacological inhibition of the H3K79 methyltransferase Dot1l","volume":"27","author":"Chen","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.05.012_bib132","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1182\/blood-2012-11-465120","article-title":"Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l","volume":"121","author":"Deshpande","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.012_bib133","doi-asserted-by":"crossref","first-page":"6912","DOI":"10.1182\/blood-2011-02-334359","article-title":"DOT1L, the H3K79 methyltransferase, is required for MLL-AF9-mediated leukemogenesis","volume":"117","author":"Nguyen","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.012_bib134","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.celrep.2015.04.004","article-title":"Degree of recruitment of\u00a0DOT1L to MLL-AF9 defines level of H3K79 di- and tri-methylation on target genes and transformation potential","volume":"11","author":"Kuntimaddi","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.exphem.2015.05.012_bib135","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.it.2012.06.002","article-title":"Chromatin modifications as therapeutic targets in MLL-rearranged leukemia","volume":"33","author":"Deshpande","year":"2012","journal-title":"Trends Immunol"},{"key":"10.1016\/j.exphem.2015.05.012_bib136","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/dvg.20679","article-title":"Widely expressed Af17 is likely not required for embryogenesis, hematopoiesis, and animal survival","volume":"48","author":"Zhang","year":"2010","journal-title":"Genesis"},{"key":"10.1016\/j.exphem.2015.05.012_bib137","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1097-2765(02)00826-2","article-title":"A conserved RING finger protein required for histone H2B monoubiquitination and cell size control","volume":"11","author":"Hwang","year":"2003","journal-title":"Mol Cell"},{"key":"10.1016\/j.exphem.2015.05.012_bib138","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S1097-2765(02)00802-X","article-title":"Bre1, an E3 ubiquitin ligase required for recruitment and substrate selection of Rad6 at a promoter","volume":"11","author":"Wood","year":"2003","journal-title":"Mol Cell"},{"key":"10.1016\/j.exphem.2015.05.012_bib139","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.molcel.2005.11.012","article-title":"The human homolog of yeast BRE1 functions as a transcriptional coactivator through direct activator interactions","volume":"20","author":"Kim","year":"2005","journal-title":"Mol Cell"},{"key":"10.1016\/j.exphem.2015.05.012_bib140","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.molcel.2005.09.025","article-title":"Monoubiquitination of human histone H2B: the factors involved and their roles in HOX gene regulation","volume":"20","author":"Zhu","year":"2005","journal-title":"Mol Cell"},{"key":"10.1016\/j.exphem.2015.05.012_bib141","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nchembio.315","article-title":"Disulfide-directed histone ubiquitylation reveals plasticity in hDot1L activation","volume":"6","author":"Chatterjee","year":"2010","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.exphem.2015.05.012_bib142","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1073\/pnas.1301045110","article-title":"Histone H2B ubiquitin ligase RNF20 is required for MLL-rearranged leukemia","volume":"110","author":"Wang","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2015.05.012_bib143","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/nature04980","article-title":"Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9","volume":"442","author":"Krivtsov","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2015.05.012_bib144","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ccr.2010.12.014","article-title":"Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases","volume":"19","author":"Xu","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2015.05.012_bib145","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1038\/leu.2014.235","article-title":"Primary acute myeloid leukemia cells with IDH1 or IDH2 mutations respond to a DOT1L inhibitor in\u00a0vitro","volume":"28","author":"Sarkaria","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.05.012_bib146","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1182\/blood-2013-03-491571","article-title":"Mutant IDH1 promotes leukemogenesis in\u00a0vivo and can be specifically targeted in human AML","volume":"122","author":"Chaturvedi","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.012_bib147","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.stem.2013.12.016","article-title":"Proto-oncogenic role of mutant IDH2 in leukemia initiation and maintenance","volume":"14","author":"Kats","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2015.05.012_bib148","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.biophys.34.040204.144452","article-title":"Structural and sequence motifs of protein (histone) methylation enzymes","volume":"34","author":"Cheng","year":"2005","journal-title":"Annu Rev Biophys Biomol Struct"},{"key":"10.1016\/j.exphem.2015.05.012_bib149","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/gb-2005-6-8-227","article-title":"The SET-domain protein superfamily: protein lysine methyltransferases","volume":"6","author":"Dillon","year":"2005","journal-title":"Genome Biol"},{"key":"10.1016\/j.exphem.2015.05.012_bib150","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0092-8674(03)00114-4","article-title":"Structure of the catalytic domain of human DOT1L, a non-SET domain nucleosomal histone methyltransferase","volume":"112","author":"Min","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2015.05.012_bib151","doi-asserted-by":"crossref","first-page":"8972","DOI":"10.1021\/jm4007752","article-title":"A medicinal chemistry perspective for targeting histone H3 lysine-79 methyltransferase DOT1L","volume":"56","author":"Anglin","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.exphem.2015.05.012_bib152","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1747-0285.2011.01135.x","article-title":"Chemogenetic analysis of human protein methyltransferases","volume":"78","author":"Richon","year":"2011","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.exphem.2015.05.012_bib153","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ccr.2011.06.009","article-title":"Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor","volume":"20","author":"Daigle","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2015.05.012_bib154","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/cbdd.12050","article-title":"Conformational adaptation drives potent, selective and durable inhibition of the human protein methyltransferase DOT1L","volume":"80","author":"Basavapathruni","year":"2012","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.exphem.2015.05.012_bib155","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.3324\/haematol.2014.115337","article-title":"MLL partial tandem duplication leukemia cells are sensitive to small molecule DOT1L inhibition","volume":"100","author":"K\u00fchn","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2015.05.012_bib156","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1182\/blood-2013-04-497644","article-title":"Potent inhibition of DOT1L as treatment of MLL-fusion leukemia","volume":"122","author":"Daigle","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.012_bib157","doi-asserted-by":"crossref","first-page":"16746","DOI":"10.1021\/ja206312b","article-title":"Selective inhibitors of histone methyltransferase DOT1L: design, synthesis, and crystallographic studies","volume":"133","author":"Yao","year":"2011","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.exphem.2015.05.012_bib158","doi-asserted-by":"crossref","first-page":"8066","DOI":"10.1021\/jm300917h","article-title":"Synthesis and structure\u2013activity relationship investigation of adenosine-containing inhibitors of histone methyltransferase DOT1L","volume":"55","author":"Anglin","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.exphem.2015.05.012_bib159","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1039\/c3md00021d","article-title":"Synthesis, activity and metabolic stability of non-ribose containing inhibitors of histone methyltransferase DOT1L","volume":"4","author":"Deng","year":"2013","journal-title":"Medchemcomm"},{"key":"10.1016\/j.exphem.2015.05.012_bib160","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.bmc.2013.01.049","article-title":"Bromo-deaza-SAH: a potent and selective DOT1L inhibitor","volume":"21","author":"Yu","year":"2013","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.exphem.2015.05.012_bib161","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/ncomms2304","article-title":"Catalytic site remodelling of the DOT1L methyltransferase by selective inhibitors","volume":"3","author":"Yu","year":"2012","journal-title":"Nat Commun"},{"key":"10.1016\/j.exphem.2015.05.012_bib162","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/bdd.1889","article-title":"Nonclinical pharmacokinetics and metabolism of EPZ-5676, a novel DOT1L histone methyltransferase inhibitor","volume":"35","author":"Basavapathruni","year":"2014","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.exphem.2015.05.012_bib163","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1182\/blood.V124.21.387.387","article-title":"The DOT1L inhibitor EPZ-5676: safety and activity in relapsed\/refractory patients with MLL-rearranged leukemia","volume":"124","author":"Stein","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.05.012_bib164","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nm.3832","article-title":"DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia","volume":"21","author":"Chen","year":"2015","journal-title":"Nat Med"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X15001940?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X15001940?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T01:07:28Z","timestamp":1654909648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X15001940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":164,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0301472X15001940"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2015.05.012","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting DOT1L and HOX gene expression in MLL-rearranged leukemia and beyond","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2015.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}